Principal Securities’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,498
Closed -$85.8K 3421
2025
Q3
$85.8K Buy
2,498
+176
+8% +$5.05K ﹤0.01% 1664
2025
Q2
$62.8K Buy
2,322
+413
+22% +$12K ﹤0.01% 1763
2025
Q1
$75.6K Hold
1,909
﹤0.01% 1562
2024
Q4
$75.6K Buy
1,909
+485
+34% +$18.4K ﹤0.01% 1559
2024
Q3
$48.5K Buy
1,424
+436
+44% +$12.3K ﹤0.01% 1706
2024
Q2
$21.4K Buy
988
+192
+24% +$4.04K ﹤0.01% 2040
2024
Q1
$17.6K Buy
796
+74
+10% +$1.8K ﹤0.01% 2065
2023
Q4
$19.9K Buy
+722
New +$17.4K ﹤0.01% 1922

Other funds holding VCYT

Principal Securities's VCYT Position: Q4 2025 in Review

Principal Securities sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 2,498 shares — an estimated $85.8K sold.

Principal Securities first reported a position in VCYT in Q4 2023 and held it in 8 quarters. The position peaked at $85.8K in Q3 2025. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Principal Securities reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 2,498 Veracyte shares in Q4 2025, an estimated $85.8K.
  • Principal Securities first reported a position in Veracyte in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Veracyte position peaked at $85.8K in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.